14 March 2019

Apply now: Donald Heath Lecturer in Cardiopulmonary Science


The University of Sheffield are seeking a lecturer who has either a strong track record in functional genomics/applied bioinformatics with broad experience in genetics, clinical bioinformatics and next generation sequencing analysis, or applied translational biomedical science using in vitro and in vivo models. In either case, you must be familiar with the application of your skills to produce translationally focused research outputs. 

You will be responsible for the development of a high-quality research programme which attracts external research funding and delivers high quality scientific discoveries and published outputs. You will have a PhD (or equivalent higher degree) in the area of cardiopulmonary physiology, molecular biology, computer science, bioinformatics, biomedical engineering, or another relevant field with a computational component.  You will also have significant post-doctoral experience in cardiovascular biology, functional genomics or experience in analysing datasets from genomics, epigenomics, transcriptomics, proteomics and metabolomics.

Alan Lawrie & Andrew Swift

You will work alongside Prof Allan Lawrie (https://www.sheffield.ac.uk/iicd/profiles/lawrie) and join the Pulmonary Vascular Research group in the Department of Infection, Immunity & Cardiovascular Disease (IICD) (http://www.sheffield.ac.uk/cardiovascularscience/index) within the Faculty of Medicine, Dentistry and Health, and the Donald Heath Research Programme in Pulmonary Hypertension Research. The Donald Heath research programme in PH (https://donaldheath.org) was founded in 2015 and is built upon strong collaborative links between Professor David Kiely (Sheffield Pulmonary Vascular Disease Unit Director), Professor Allan Lawrie (British Heart Foundation Senior Basic Science Research Fellow) and Professor Jim Wild (National Institute for Health Research Professor) which has driven forward the growth of PH research in Sheffield over the past 15 years.

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI